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Oxytocin neuron computational model 
A predictive, quantitative model of spiking activity and stimulus-secretion 
coupling in oxytocin neurons 
Jorge Maícas-Royo, Gareth Leng, Duncan J MacGregor 
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK 
Received 26 October 2017. Accepted 08 January 2018. 
Oxytocin neurons of the rat hypothalamus project to the posterior pituitary where they secrete 
their products into the bloodstream. The pattern and quantity of that release depends on the 
afferent inputs to the neurons, on their intrinsic membrane properties, and on non-linear 
interactions between spiking activity and exocytosis: a given number of spikes will trigger 
more secretion when they arrive close together. Here we present a quantitative computational 
model of oxytocin neurons that can replicate the results of a wide variety of published 
experiments. The spiking model mimics electrophysiological data of oxytocin cells 
responding to cholecystokinin (CCK), a peptide produced in the gut after food intake. The 
secretion model matches results from in vitro experiments on stimulus-secretion coupling in 
the posterior pituitary. We mimic the plasma clearance of oxytocin with a two-compartment 
model, replicating the dynamics observed experimentally after infusion and injection of 
oxytocin. Combining these models, allows us to infer, from measurements of oxytocin in 
plasma, the spiking activity of the oxytocin neurons that produced that secretion. These 
inferences we have tested with experimental data on oxytocin secretion and spiking activity 
in response to intravenous injections of CCK. We show how intrinsic mechanisms of the 
oxytocin neurons determine this relationship: in particular, we show that the presence of an 
after-hyperpolarization (AHP) in oxytocin neurons dramatically reduces the variability of 
their spiking activity, and even more markedly reduces the variability of oxytocin secretion. 
The AHP thus acts as a filter, protecting the final product of oxytocin cells from noisy 
fluctuations. 
We present a model of oxytocin neurons that relates secretion to spike activity. We fit this to 
experimental data, and use it to explore the significance of intrinsic membrane properties. 
Introduction 
Magnocellular oxytocin neurons in the supraoptic nucleus (SON) and paraventricular nucleus 
of the hypothalamus project their axons to the posterior pituitary where they secrete their 
hormones into the bloodstream. Oxytocin has an indispensable role in breastfeeding and an 
important one in parturition (1), but the secretion of oxytocin is also regulated by a variety of 
metabolic signals arising from the gastrointestinal tract, and, in the rat, oxytocin secretion 
also regulates sodium excretion and gut motility (2). 
The membrane properties of these neurons have been studied extensively by 
electrophysiological studies in vitro (3–6). In these neurons, spikes are typically triggered by 
the arrival of excitatory inputs (excitatory postsynaptic potentials; EPSPs) from diverse brain 
areas. Whenever a spike is produced, Ca2+ enters the cell through voltage-activated channels 
and subsequently activates K+ channels that mediate post-spike hyperpolarisations. Large 
conductance (BK) channels open and close rapidly, producing a short hyperpolarizing 
afterpotential (HAP) which makes the neurons relatively inexcitable for 30-50ms (7). Small 
conductance (SK) channels produce a medium afterhyperpolarization (AHP). This is much 
smaller than the HAP, but the half-life is much longer (about 350ms), so the AHP 
accumulates over successive spikes, and the resulting level of activity-dependent 
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hyperpolarization will reflect the average level of spike activity over the preceding few 
seconds (7). Some oxytocin neurons also generate an activity-dependent depolarising 
afterpotential (DAP) (8), but this is usually quite small and masked by the larger activity-
dependent hyperpolarisations. 
The patterning of spikes generated by these neurons has also been studied extensively in 
vivo (4,9–11). In lactating rats, suckling induces brief intense bursts of spikes in oxytocin 
cells, but other stimuli produce graded increases in spike activity. For example, intravenous 
(i.v.) injections of cholecystokinin (CCK) produce a dose-dependent increase in spike activity 
that lasts for 10-15 min (12–16), producing a transient increase in plasma oxytocin. CCK is 
secreted from the duodenum in response to a meal and acts at CCK1 receptors on gastric 
vagal afferents; these project to neurons in the nucleus tractus solitarii, which in turn project 
directly to magnocellular oxytocin neurons (17,18). The subsequent secretion of oxytocin is 
thought to regulate gut motility and sodium excretion at the kidneys (19,20). 
The spontaneous spiking activity of oxytocin neurons can be matched by a modified 
leaky integrate-fire model, which incorporates a HAP and an AHP (7,21). This model can 
closely match the statistical features of spike patterning in oxytocin neurons, as reflected by 
the interspike interval distribution and the index of dispersion of spike rate. Given this, it 
should be possible to use the model to infer the synaptic input that oxytocin cells receive 
when responding, for example, to CCK, if we assume that the CCK-evoked input consists 
solely of a change in excitatory input rate. 
Our previous work indicates that the AHP in oxytocin neurons, by acting as an activity-
dependent negative feedback, reduces the second-by-second variability (index of dispersion) 
in the firing rate of oxytocin cells (21). Because of particular features of stimulus-secretion 
coupling in these neurons, this “regularisation” of firing rate is likely to be most important 
during dynamic challenges to oxytocin cell activity. In oxytocin neurons, secretion is a non-
linear function of spike activity: a given number of spikes secrete more oxytocin when they 
are close together than when sparsely distributed. This nonlinearity is marked: during a reflex 
milk ejection, oxytocin cells fire about 100 spikes in just 2 s (22), and during this burst, each 
spike releases, on average, about 100 times as much oxytocin as spikes that occur at the 
typical basal firing rate of 2 spikes/s (23). Because of this non-linearity, the oxytocin 
secretion from a single cell depends not only on its mean firing rate but also on the variability 
of its firing rate, due to the disproportionate influence of high firing rate fluctuations. 
The mechanisms of stimulus-secretion coupling are complex, but we recently published a 
model of stimulus-secretion coupling in magnocellular vasopressin cells fitted to data on 
stimulus-evoked vasopressin secretion (24). The properties of vasopressin terminals differ 
quantitatively from those of oxytocin terminals, and here we modified the vasopressin 
secretion model to fit the properties of oxytocin terminals (25–27). Combining the spiking 
model of oxytocin neurons with this secretion model allows us to model the activity-
dependent output of oxytocin cells. To predict the consequences for plasma concentrations, 
we also introduced a model of the clearance of oxytocin from plasma. For this there is good 
historical data (28–30). Applying this allows us to predict, from the model, the plasma 
oxytocin concentration that will result from a given stimulus to the oxytocin cells. In the case 
of CCK, again there is published data to compare with the model. This allows us to assess the 
importance of the AHP not only for spike activity but also for the important biological signal 
– the resulting change in plasma oxytocin concentration. 
Methods 
We used a previously described model for the spiking activity of oxytocin neurons (24; 
parameters given in Table 1) and adapted a published model of stimulus-secretion coupling in 
vasopressin neurons to model oxytocin secretion (24).  We also added a two-compartment 
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3
model to mimic the dynamics of oxytocin concentration in plasma (Fig. 1). The models were 
developed using software written in C++ and a graphical interface based in the open source 
wxWidgets library.  Simulations were run for up to 10,000 s using a 1-ms step.  
Spiking model 
The integrate-and-fire based spiking model (21) simulates the firing activity of oxytocin cells 
in response to EPSPs and inhibitory postsynaptic potentials (IPSPs). We model PSPs as 
arriving randomly at mean rates Ire and Iri, and in this study, we fixed Iri to be equal to Ire. 
Thus, the time an EPSP arrives, epsptime is defined by: 
 
( )log 1
,  where  is a random number between 0 and1 time
re
rand
epsp rand
I
− −
=
 ( I ) 
The IPSP arrival times follow the same formula. 
Responses to CCK 
We mimicked the effect of i.v. injection of CCK by adding an additional random EPSP 
contribution, with mean rate IrCCK. The total EPSP rate is the sum of Ire and IrCCK. 
The increase in EPSP rate during simulated CCK injection follows a linear function 
kCCK/CCKdur defined by the quantity of CCK injected, kCCK, and the duration of the injection, 
CCKdur.  
We assume that CCK is cleared from plasma following an exponential decay with time 
constant τCCK. 
  when 
CCK
rCCK
durrCCK
start start dur
CCK
k ICCKdI CCK t CCK CCK
dt τ
 
− 
 
= ≤ ≤ +
  
( II )
 
 
  when  rCCK rCCK start dur
CCK
dI I
t CCK CCK
dt τ
−
= > +
 
( III )
 
where CCKstart is the injection’s start time. 
Time constants are calculated from half-life parameters by: 
 
( )ln 2
x
x
λ
τ =
 
( IV )
 
We fixed the magnitude of EPSPs and IPSPs, epsph and ipsph, at 2 mV, having an opposite 
sign for EPSPs and IPSPs. The final input depends on the number of inputs, epspn and ipspn, 
per unit of time (fixed at 1ms in our simulations). epspn is the number of EPSPs obtained in a 
given time unit from a random process with mean rate Ire. 
 
. .h n h nI epsp epsp ipsp ipsp= +
 
( V )
 
Vsyn represents the contribution of synaptic input to the membrane potential V, and decays to 0 
with time constant τsyn corresponding to a half-life λsyn of 3.5 ms. 
 
syn syn
syn
dV V
I
dt τ
= − +
 
( VI )
 
Initially, the model neuron is at a resting potential, Vrest = -56mV. If inputs summate to 
increase the membrane potential V above a threshold Vth = -50mV, the neuron produces a 
spike. Then, the model triggers a HAP and an AHP, and V evolves according to 
 
rest synV V V HAP AHP= + − −
 
(VII)
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4
HAP has a fixed amplitude (kHAP = 30mV) and a time constant,  τHAP , that corresponds to a 
half-life of 7.5 ms, following values from previous work (21). AHP also has a fixed 
amplitude (kAHP = 1) and τAHP was set to correspond to a half-life λAHP of 350 ms as used 
previously (21); we explored different values of  kAHP in the range of values (0.2-1.4) found 
previously from fits to individual oxytocin neurons (21); the results were qualitatively similar 
for other values of kAHP. 
 HAP
HAP
dHAP HAP k
dt
δ
τ
− + ⋅=
 
(VIII)
 
 AHP
AHP
dAHP AHP k
dt
δ
τ
− + ⋅=
 
(IX)
 
where δ  = 1 if a spike is fired at time t, and δ  = 0 otherwise.   
Secretion model 
The secretion model is an adaptation of the model of MacGregor and Leng (24), developed to 
mimic stimulus-secretion coupling in vasopressin neurons. When spikes invade the secretory 
terminals, exocytosis occurs at sites close to clusters of voltage-gated Ca2+ channels. These 
sites experience transiently high Ca2+ concentrations in response to spikes, but the Ca2+ 
swiftly diffuses into the cytosol (31). This is represented by making secretion proportional to 
a ‘fast’ Ca2+ variable e. At increased frequencies, the spikes broaden (32,33), producing a 
larger rise in e. The resulting facilitation of secretion is limited by activity-dependent 
attenuation of secretion, modeled as arising from Ca2+-dependent inactivation of Ca2+ 
channels in the submembrane compartment, and by activation of Ca2+-dependent K+ 
channels. The model consists of differential equations which take as input the spike events 
generated by the spiking model. Variables representing spike broadening (b), cytosolic Ca2+ 
concentration (c) and submembrane Ca2+ concentration (e) are all incremented with each 
spike. The Ca2+ variables model Ca2+ mediated signals at specific action sites: we did not 
attempt to represent the full dynamics of intracellular calcium changes. 
We model spike broadening b by increasing it by kb = 0.021 when a spike arrives, and 
with an exponentially decay with half-life λb = 2 s: 
 b
b
db b k
dt
δ
τ
− + ⋅=
 
( X )
 
where δ  = 1 if a spike is fired at time t, and δ  = 0 otherwise. 
The Ca2+ entry, Caent, provoked by spikes has two other effects. c and e measure how the 
concentration of Ca2+ changes at the cytosol and in the submembrane compartment. They are 
incremented by kc = 0.0003 and ke = 1.5 with every spike and decay with half-lives λc = 20 s 
and λe = 100 ms: 
 c ent
c
dc c k Ca
dt
δ
τ
= − + ⋅ ⋅
 
( XI )
 
 e ent
e
de e k Ca
dt
δ
τ
= − + ⋅ ⋅
 
( XII )
 
where δ  = 1 if a spike is fired at time t, and δ = 0 otherwise. 
Ca2+ entry depends on spike broadening (b), and is subject to Ca2+-dependent inhibition: 
 ( )ent inhib inhib baseCa e c b b= +⋅ ⋅  ( XIII ) 
The basal level of spike broadening is given by bbase = 0.5. Ca2+ entry is inhibited by c and e 
using two inverted Hill equations with threshold and coefficient parameters, cθ = 0.14, eθ = 
12, cn = 5 and en = 5: 
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1
n
n n
c
inhib c c
c
c
c cθ
= −
+
 
( XIV )
 
 
1
n
n n
e
inhib e e
e
e
e eθ
= −
+
 
(XV)
 
The releasable vesicle pool (p) is depleted with secretion, s, and refilled when not full (pmax = 
5 ng) at a rate proportional to the remaining reserve pool (r) divided by its maximum capacity 
(rmax = 1 µg). The refill rate is scaled by β = 120: 
 
   when ,   otherwisemax
max
dp r
s p p s
dt r
β= − + < −⋅
 
( 
XVI )
 
The reserve pool is depleted exponentially as it refills p, with its maximum (initial) value 
defined by rmax: 
 
   when ,  0 otherwisemax
max
dr r p p
dt r
β ⋅= − <
 
( XVII )
 
The rate of secretion (s) is the product of e raised to the power  (because of the 
cooperativeness of the Ca2+ activation of exocytosis) (34), the releasable pool (p) and a 
scaling factor α 
 s e pϕ α= ⋅ ⋅
 
( XVIII )
 
The parameters of the vasopressin model were fitted to data obtained for secretion from the 
whole neural lobe – containing the axons of up to 9000 neurons (35,36). Thus parameters 
relevant to quantities of secretion (p, pmax , r and rmax) from the whole population are about 
nine thousand times higher than would be appropriate for single cells. The same approach 
was taken here, and the same ‘correction factor’ applies. 
To adapt this model to match oxytocin secretion, we made six changes from the 
parameters of the vasopressin model (24); the new parameters are given in Table 2. 
1) We decreased kb from 0.05 to 0.021, reducing the spike broadening.  
2) We reduced the sensitivity to Ca2+ entry in the submembrane compartment, by increasing eθ from 2.8 to 
12.  
3) We increased cθ from 0.07 to 0.14.  
4) We reduced the cooperativeness of the Ca2+ activation of exocytosis from  = 3 to  = 2.  
5) We increased α, a scaling factor, to 3 to match the levels of oxytocin measured in plasma.  
6) We increased β, the refill rate of the pools from the reserve, from 50 to 120.  
The results mimic the secretion of the entire population by considering that the average 
response of the population can be mimicked by the response of a single oxytocin cell 
multiplied by a scaling factor. 
Two-compartment diffusion model  
To simulate how the oxytocin that enters the plasma (x) is cleared, we developed a two-
compartment model. Secreted oxytocin enters the plasma volume (Cplasma), and is cleared 
from it mainly through the kidneys and liver. The second compartment represents the 
extravascular fluid compartment (CEVF), and oxytocin diffuses between these two 
compartments according to the concentration gradient. The clearance from plasma and the 
diffusion between compartments follow exponential differential equations with a clearance 
half-life λcl, of 68s and a diffusion half-life λdiff of 61s (Table 3), values derived from 
reference data described below: 
 
 
clr diff
dx x DiffRate
s
dt τ τ
= − −
 
(XIX)
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6
The oxytocin content in plasma (x) and extravascular fluid (xEVF) change due to diffusion 
between the compartments following the oxytocin concentration gradient (DiffRate):  
 
 (  )
2
plasma EVFEVF
plasma EVF
C CxxDiffRate C C
+
= − ⋅
 
(XX)
 
 
  
EVF
diff
dx DiffRate
dt τ
=
 
(XXI)
 
Reference data 
To fit the spiking model, we used a library of recordings of oxytocin neurons in urethane-
anesthetised rats. Full details of these experiments have been published previously 
(15,16,37). In brief, neurons were recorded from the supraoptic nucleus using a 
transpharyngeal surgical approach, and were antidromically identified as projecting to the 
posterior pituitary. Oxytocin neurons were identified by their excitatory responses to i.v. 
injection of CCK, and spike times were collected using Spike2 software (CED). Model data 
was compared to recorded spike activity by comparing the interspike interval distributions (in 
5-ms bins) and by comparing the index of dispersion of firing rate, calculated as the ratio of 
variance to mean rate for binwidths of 0.5, 1, 2, 4 and 8 s. 
To fit the secretion model, we used data from three independent data sets: 
1. In Bicknell et al. (25) and Bicknell (26), oxytocin release from isolated rat posterior pituitaries was 
measured by radioimmunoassay after:  
• 20-min periods of 13 Hz stimulation  
• 18, 36, 54 and 72-s periods at 13 Hz  
• 156 pulses at 6.5, 13, 26 and 52 Hz 
2. In Bondy et al. (27), rat posterior pituitaries were stimulated with 600 pulses at 1, 4, 8, 12, 20 and 30 
Hz. The released oxytocin was measured by radioimmunoassay and normalized to release evoked by 
600 pulses at 12 Hz. 
To fit the diffusion model, we matched data from experiments in rats described by Fabian 
et al. (29) and Ginsburg and Smith (28), who measured plasma oxytocin by bioassays. 
Ginsburg and Smith reported that in male rats, a 440 ng/100 g bolus injection of oxytocin 
disappears from plasma with an apparent half-life of 1.65 ± 0.13 min (1.73 ± 0.1 min in 
female rats). Fabian et al. found that, after a constant 30 min infusion of oxytocin at rates 
between 550 and 13200 pg/min/100 g body weight, plasma oxytocin concentrations fell to 
50% of the initial value in a median time of 126 s, and continuously infused oxytocin was 
distributed in an apparent volume of 7.3 ml/100 g body weight. Assuming a plasma volume 
of 3.4 ml/100g body weight, we calculate a plasma compartment, Cplasma = 8.5 ml for a 250 g 
rat, and an extravascular fluid compartment CEVF = 9.75 ml. Fabian et al. measured the peak 
concentrations just before they stopped their infusions (Table 3). Ginsburg and Smith 
measured the peak value 1 min after the injection of 440 ng/100 g oxytocin in male rats 
(average 46 ng/ml). Finally, we mimic the clearance found in rats with the kidneys or the 
splanchnic area clamped and with both areas clamped (Tables 3 and 4). 
To fit the combined model, which includes the spiking, secretion and diffusion, we used 
four sets of plasma measurements of oxytocin from independent experiments in which rats 
were given an i.v. injection of CCK.  
- conscious virgin female rats, in which blood samples were taken before and after i.v. injection of 20 
µg/kg CCK (38).  
- conscious male rats in which blood samples taken before and after i.v. injection of 10 µg/kg CCK (19). 
- two groups of anaesthetized female rats, in which blood samples were taken before and after  i.v. 
injection of 20 µg/kg CCK (39).  
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Results 
Reference data 
We selected 23 recordings from oxytocin neurons that showed a fast and clear response to 
CCK and in which the firing rate subsequently returned to the initial level.  The 23 cells had a 
mean (SD) spontaneous firing rate of 2.5 (0.39) spikes/s (range 0.02-7.9 spikes/s), measured 
as the average over 4-min before injection. The cells responded to i.v. injections of 20 µg/kg 
CCK with a mean increase of 1.46 (0.74) spikes/s (range 0.57-3.6 spikes/s), measured as the 
difference between the basal firing rate and the average over the 5-min after the injection 
(Fig. 2a). The decay of the mean response from 50 s after injection was well fitted by a single 
exponential equation with a half-life of 230 s (R2 =0.88) (Fig. 2a). 
Spiking model 
For the spiking model we chose a basal mean PSP rate of 292/s (basal EPSP rate is equal to 
basal IPSP rate) to match the spontaneous firing rate of 2.5 spikes/s. After 5 min of basal 
activity, we simulated an injection of CCK as a linear increase in mean EPSP frequency over 
20 s that declined exponentially to the basal EPSP rate with a half-life of 230 s. These values 
gave a close match to the average response profile of the reference set of oxytocin neurons to 
CCK (Fig. 2b). Figure 2b shows the average of 23 runs of the spiking model. The variability 
of this average is less than the variability of the average of the reference data: the 23 model 
neurons are all identical and firing at the same mean rate, while the neurons in the reference 
data differed in intrinsic properties and mean firing rates. 
The spiking model reproduces various statistical characteristics of single oxytocin cells 
(Fig 2c). Thus, for the neuron shown in Figure 2, by modifying only the basal PSP rate (Table 
1b), the model matches mean spike rate over the whole recording (Fig. 2c1), simulating the 
firing rate increment response as an increase in EPSP rate that modifies the oxytocin neuron 
spiking activity (Fig. 2c2). The model also matches well the interspike interval distribution 
(Fig. 2c3), and mimics the index of dispersion of the firing rate during the complete 
recording, which measures the variability of spike rate at different bin widths (Fig. 2c4). 
Secretion model 
To model stimulus-secretion coupling, we modified the previously published vasopressin 
secretion model (24) to match data from three experiments where oxytocin secreted from 
isolated posterior pituitaries was measured. We mimicked these protocols in the spiking 
model, progressively adapting the secretion model to fit the oxytocin data by changing six 
parameter values (kb, cθ, eθ, β, α and ). 
In the first of these experiments (26), 156 pulses at 6.5, 13, 26 and 52 Hz were applied to 
the posterior pituitaries (Fig. 3a1). The second source of experimental data (27) followed a 
similar protocol, this time stimulating with 600 pulses at 1, 4, 8, 12, 20 and 30 Hz (Fig. 3a3). 
In the third set of data (25), isolated rat posterior pituitaries were stimulated in vitro at 13 
Hz for 18, 36, 54 and 72 s in a randomised order (Fig. 3b1). This third set of data are critical 
for estimating the temporal profile of secretion, and they showed that, unlike vasopressin 
secretion, which shows fatigue, oxytocin secretion is relatively stable over time in response to 
a constant frequency of stimulation. The modified model fits all three sets of data well (Fig. 
3a2, a3, b2). 
How the changes in model parameters were arrived at is illustrated in Figure 4. In the 
vasopressin model, the submembrane Ca2+ concentration (e), which has a direct role in 
exocytosis (equation XIX), displays fatigue at a firing rate of 13 spikes/s, and the rate of 
secretion declines during constant stimulation (Fig. 4a). This is inconsistent with the 
experimental oxytocin data. In addition, vasopressin secretion per pulse declines at 
frequencies above 13 Hz, whereas oxytocin secretion is facilitated. Reducing the broadening 
of spikes kb (Fig. 4b1) reduces secretion at low frequencies and increases secretion at high 
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8
frequencies by reducing Ca2+-induced inhibition of Ca2+ entry, and reduces but does not 
eliminate the fatigue. Increasing eθ to weaken the Ca2+-induced inhibition of Ca2+ entry 
enhances secretion, particularly at high frequencies (Fig. 4b2), but fatigue is much more 
prominent after this change. Raising cθ, to reduce the sensitivity to cytosolic Ca2+, reduces 
Ca2+-induced inhibition of Ca2+ entry and so eliminates fatigue. Combining these three 
changes matched the frequency response (Fig. 4c). To match the slope of the temporal 
response to a constant frequency of 13 Hz, we also needed to change the exponent in the 
secretion equation, , from 3 in the vasopressin model to 2, indicating a smaller cooperative 
activation of exocytosis (34). 
The constant factor α scales the output of the model quantitatively to measured oxytocin 
levels. In rats, milk-ejection bursts typically contain about 100 spikes over about 2 s and 
release about 1 mU (2.2 ng) of oxytocin (22). Setting α = 3, the model simulates a release of 
~2.27 ng in response to 2 s of stimulation at 50 spikes/s. This increase necessitated an 
increase in the scaling factor for the pool refill rate, β, from 50 to 120. 
Spiking plus secretion model 
We used the combined model to explore how the spiking response to CCK varies with the 
dose of CCK and with the basal firing rate, and how that response affects secretion. We chose 
basal firing rates 1, 3 and 5 spikes/s, spanning the range in the reference data, and simulated 
CCK injections of 5, 10 and 20 µg/kg. Each combination was run 20 times (differing by the 
random differences in PSP arrival times) and the results were averaged. Each response was 
calculated as the difference between the average firing rate in the 25 s after the peak response 
and the basal firing rate (determined after allowing enough time for the model simulation to 
reach equilibrium of secretion). Comparing responses for the same CCK dose and different 
basal firing rates (Fig. 5a1), the response to CCK is largely independent of the basal firing 
rate in the range 1-7 spikes/s. At 20 µg/kg, where there is the biggest difference, the response 
from a basal firing rate of 1 spike/s (3.5 spikes/s) is 30% greater than that from a basal rate of 
7 spikes/s (2.7 spikes/s). 
This consistency in firing rate responses to a given dose of CCK is not present in the 
secretory response, similarly calculated as the difference between basal levels and evoked 
levels. At higher basal firing rates, the secretory response is much greater than from a basal 
firing rate of 1 spike/s for all doses of CCK (5, 10, 20 µg/kg; Fig. 5a2). The relationship 
between EPSP rate and firing rate in the oxytocin cell model is approximately linear over the 
range modelled here (7) so the firing rate increment in response to CCK is relatively 
independent of basal firing rate. However, the frequency dependence of stimulus-secretion 
coupling makes the secretory response to CCK non-linearly dependent on the absolute firing 
rate achieved in response to CCK. Hence the secretory response to CCK depends on both the 
basal firing rate and the dose of CCK. 
The influence of the AHP was examined by comparing the response of the model with 
and without an AHP (i.e. setting kAHP = 0) for a CCK injection of 20 µg/kg. With an AHP, the 
spiking response to CCK (about 4 spikes/s at peak; Fig 5b1) is much less than without an 
AHP (about 11 spikes/s; Fig 5b2). In the presence of an AHP, the profile of secretion follows 
that of spike activity smoothly (Fig. 5b3). By contrast, without an AHP, when the basal firing 
rate is 7 spikes/s, the initial high level of secretion evoked by CCK rises sharply from 40 pg/s 
to 235 pg/s in response to CCK, but decreases abruptly to 110 pg/s within 20 s before 
declining more smoothly (Fig. 5b4). 
To understand this behavior, we simulated a similarly large spike response in the presence 
of an AHP. From a basal firing rate of 1 spike/s, a simulated CCK injection of 40 µg/kg 
evoked a response of 8 spikes/s (Fig. 5c1), and was accompanied by a smooth secretory 
response (Fig. 5c2). A larger CCK injection (100 µg/kg) evoked a response of 18 spikes/s 
(Fig. 5c3), and the accompanying secretory response rose sharply and decreased abruptly 
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(Fig. 5c4), as observed in the model without an AHP (Fig. 5b4). This feature is because of the 
fatigue associated with Ca2+-induced inhibition of Ca2+ entry (Fig. 5c1,c3), which becomes 
noticeable only above firing rates of 13 spikes/s. Thus, in the model, an abrupt pulse of 
oxytocin secretion can arise at the onset of a sustained increase in activity to a level 
exceeding 10 spikes/s. 
The diffusion model  
To model the oxytocin concentration in plasma, we simulated experiments that measured the 
half-life of oxytocin in plasma and its apparent volume of distribution following i.v. infusions 
of oxytocin in normal rats and in rats where the blood supply to the kidneys and/or the 
splanchnic was clamped (Fig. 6a). We created a two-compartment model where oxytocin 
secretion first enters a plasma compartment with volume Cplasma = 8.5 ml from which it is 
cleared, and from which it diffuses to an extravascular compartment of volume CEVF = 9.75 
ml (Fig. 1); these volumes are as estimated by Fabian et al. (29). We chose a diffusion half-
life (λdiff = 61s) compatible with the diffusion of NaCl between plasma and extravascular fluid 
(40). With those parameters, we matched the experimental data from continuous infusion 
studies (29) with a clearance half-life λclr = 68 s (Table 3). Using the same parameter values, 
we can also match the observed oxytocin clearance after a bolus injection of oxytocin (28) 
(Fig. 6b). 
Spiking, secretion and diffusion models combined 
Combining the spiking, the secretion and the diffusion models, we tried to match the oxytocin 
plasma concentration measured in experiments where CCK was injected in rats. In the first 
experiment (38), 23 rats were injected with 20 µg/kg CCK. In the second, seven rats were 
injected with 10 µg/kg CCK (19). Lastly, two groups of 39 and 25 rats were injected with 20 
µg/kg CCK (39). In all cases, oxytocin was measured by radioimmunoassay, but in the first, 
third and fourth cases, the assay used was that of Higuchi et al. (41) and oxytocin was 
measured in unextracted plasma. The second set of data measured oxytocin after plasma 
extraction using a different antibody. 
We matched the first set of data (Fig. 6c1) by simulating a basal firing rate of 2.4 spikes/s, 
increasing the EPSP rate after 5 min with a simulated injection of 20 µg/kg CCK (i.e. by the 
amount determined by the fits of the spiking model to neuronal responses to CCK; Fig. 2). In 
the second set of data, the oxytocin concentration did not return to the original baseline level 
after the CCK injection, and we simulated a basal firing rate of 0.8 spikes/s that fit the final 
oxytocin concentration, not the initial concentration (Fig. 6c2). In the third set of data, we 
simulated a basal firing rate of 1.7 spikes/s to match the average of initial and final oxytocin 
concentrations (Fig. 6c3) and in the final set, we matched initial and final oxytocin 
concentrations with a basal firing rate of 0.9 spikes/s (Fig. 6c4). For each set of data, there is 
a close match to the oxytocin concentrations measured in the 15 min after CCK injection. 
The role of the AHP 
As shown previously (21), the AHP “smooths” the firing rate of oxytocin cells reducing its 
variability, and it reduces the amplitude of the response to CCK (Fig. 7a). As we predicted, 
the AHP has an even bigger effect in reducing the variability (SD) of basal oxytocin secretion 
(Fig. 7b) and basal oxytocin concentrations (Fig. 7c). 
We went on to study why this reduction in variability might be important. We used the 
model to mimic the same firing rate response to a simulated challenge with and without an 
AHP. We ran the model with an AHP 20 times (randomising the PSP arrival times) to 
produce an average basal firing rate of 1.5 spikes/s, and simulated the response to 10 µg/kg 
CCK. Then, we ran the model without an AHP, adjusting the mean PSP rate to produce the 
same average basal firing rate, and challenged it with a simulated injection of 5 µg/kg CCK 
to evoke a similar firing rate response. Although the firing rate responses to CCK are similar 
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in magnitude, they differ in variability. With an AHP, the mean (SD) second-by second 
coefficient of variation of firing rate (SD/mean) in the 20 runs for the 50 s before CCK plus 
the 300 s after is 0.43 (0.11) (Fig. 8a), compared to 0.60 (0.13) for the model without an AHP 
(Fig. 8b). For secretion: the corresponding coefficient of variation is 0.54 (0.12) in the model 
with an AHP (Fig. 8c), compared to 0.81 (0.17) in the model without an AHP (Fig. 8d). 
To illustrate how this reduction in variability helps to distinguish between different levels 
of mean activity, we ran the model with and without an AHP for 20 min at mean firing rates 
of 1, 4, and 7 spikes/s. The modeled secretion varies according to the history of activity and 
secretion, so we plotted the actual firing rate in each 6-s bin against the secretion in that bin 
(Fig. 8e-f). In the model with an AHP, the rates of secretion are consistently separated (Fig. 
8e), but in the model without an AHP they overlap substantially (Fig. 8f). 
Finally, we considered how the AHP affects the reliability of the signal from a single 
oxytocin neuron. We ran the model with and without an AHP, as a single neuron firing on 
average at 1, 3 and 7 spikes/s. We calculated what increase in EPSP rate in each condition 
would raise the mean firing rate by 1 spike/s on average. We then tested the model with a 
pattern of EPSPs that alternated between the higher (challenge) and lower (basal) level, for 
different durations (1-50 s), and for a total run of 100 min (Fig. 9), and compared the 
modeled total secretion during each challenge episode with that in the preceding basal 
episode. If the secretion during the challenge episode did not exceed that during the 
corresponding basal episode, we registered this as a “detection error”, and counted the 
number of such errors in each trial. 
The error rate is consistently much higher without an AHP: for example, at 3 spikes/s, 1-s 
challenge episodes are not detected in 37% of trials of a neuron without an AHP, but in only 
20% of trials of a neuron with an AHP (Fig 9c-d). 
Heterogeneity in basal firing rate and response to CCK 
In the reference data, the basal firing rate and the response to CCK are both heterogeneous: 
the mean SD of the basal firing rate (in 1-s bins) was 2.34, close to the SD = 2 reported 
previously for oxytocin neuron firing rates (37). This increased to 2.84 over the 5 min after 
injection of CCK, also consistent with previous data (15). To evaluate how that heterogeneity 
affects secretion, we ran the model with the recorded spike times of those 23 neurons, 
obtaining the predicted secretion and its mean SD (Fig 10a). 
In Figure 2, we simulated the average response of those 23 neurons using 23 runs of a 
single model neuron with randomised input arrival times at the same mean rate. This gives a 
much lower SD of firing rate (Fig. 10b1). Moreover, although the averaged modelled 
secretion was close to the predicted in vivo secretion (Fig 10b1), the mean basal secretion 
(3.34) is much lower than the predicted mean basal secretion (7.11). That leads to an 
overestimate of the predicted basal firing rate when fitting the model to plasma oxytocin 
measurements, as we did in Fig 6c. The SD of the secretion rate was also much lower. 
Therefore, we introduced heterogeneity in our model by simulating a population of 23 
neurons with independently generated values for PSP rate (Ire and Iri sampled from a 
lognormal distribution with mean (SD) = 292 (292), see Table 5) to closely match both the 
average firing rate of the reference neurons and the SD of their basal firing rate (Fig 10b2). 
However, the SD of the firing rate of the heterogeneous model cells did not change after 
CCK (2.23 at basal level and 2.24 after CCK). Consequently, the secretion rate is similar to 
the predicted secretion from the reference neurons at the baseline, but does not reach the 
predicted levels of CCK response. 
We therefore also introduced heterogeneity to the CCK response by simulating a 
lognormally distributed kCCK of mean (SD) = 20 (20). With that change, the match to the 
firing rate was still good and the SD of the basal firing rate (2.21) and the SD during the 5 
min after CCK (2.93) were close to the reference data (Fig. 10b3). In addition, the model 
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mimicked the predicted in vivo secretion closely in both average and SD (see Table 5 for the 
parameter values of the 23 neurons). 
To study the impact of the AHP, we made the AHP = 0 and, in the model without 
heterogeneity we reduced the basal PSP rate from 292 to 203.5 and kCCK from 20 to 7 to 
match the mean firing rate of the reference data (Fig 10c1). The resulting SD of the firing rate 
was 1.33 at the basal level and 1.71 after CCK (Fig 10c1). The secretion still matched the 
predicted in vivo reference data but not the SD. We then introduced heterogeneity by varying 
the PSP rate (lognormal distribution with mean (SD) = 203.5 (203.5)) and kCCK (lognormal 
distribution with mean (SD) = 7 (7)). This gave a raised mean basal firing rate of 3.06 
spikes/s, and a mean response magnitude of 1.2 spikes/s over the 5 min after CCK (Fig 10c2). 
The firing rate SD was 4.27 at basal and 4.9 after CCK, much higher than in the reference 
data. The close match to predicted secretion was lost (see Table 5 for the parameter values of 
the 23 neurons without an AHP). Thus a close match to both the mean and the variability of 
the reference data (a) was obtained by modeling a population of neurons matching the 
heterogeneity of those data using a model with an AHP, but not by using a model without an 
AHP. 
Discussion 
In the present study, we used a previously published integrate-and-fire based model of 
oxytocin neuron activity. We have shown elsewhere that this model is closely consistent with 
a Hodgkin-Huxley type model that represents the AHP and HAP in a biophysically 
meaningful way consistent with experimental data from in vitro experiments (7). Real 
oxytocin neurons vary in their intrinsic properties, in their basal firing rates, and in their 
responsiveness to CCK. In the present study, we began by considering the population of 
oxytocin neurons as identical, differing in their behavior only as a result of differences in the 
random arrival times of PSPs. The model neurons are however ‘typical’ of real oxytocin 
neurons, and we simulated a response to CCK that matches the average response of real 
neurons to CCK. We did so by the minimalist assumption that the mean rate at which EPSPs 
arrive is proportional to the CCK concentration in plasma, which decays exponentially to 
zero after bolus injection. The decay of plasma CCK estimated in the present study from the 
recordings of oxytocin cells (230 s) is close to the half-life of CCK measured in human 
plasma (about 4 min) (42). 
To this spiking model, we added a model of stimulus-secretion coupling adapted from a 
model used previously to model stimulus-secretion coupling in vasopressin neurons. We 
adapted that model to match four sets of published data on oxytocin secretion from isolated 
posterior pituitaries. 
The model expresses the rate of oxytocin secretion from a single neuron as a continuous 
variable. This understates the variability of secretion from a single cell. Oxytocin is secreted 
in discrete packets – vesicles that each contain about 85,000 molecules of oxytocin - and the 
rate at which these vesicles are secreted from a single cell at baseline is low – about 1-4/s 
(43). A more accurate model would represent secretion as a stochastic process, not as a 
continuous deterministic process. In the context of the present model, we can better 
understand the variable (s), described here as representing the rate of secretion, as rather 
reflecting the instantaneous probability of vesicle exocytosis. However, as we are using this 
model to simulate the total secretion from the population, it seemed reasonable to accept a 
continuous representation of secretion as approximating the average of many stochastic 
processes. 
The secretion model is a highly simplified representation of mechanisms in the nerve 
terminals. The terminals express a variety of Ca2+ channels (44) and there is evidence that 
Ca2+ release from intracellular stores also has a role (45). Exocytosis is also modulated by 
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activity-dependent secretion of several modulators, including ATP (46), adenosine (47) and 
endogenous opioids (48,49). The terminals do not contain clearly separate pools of readily-
releasable and reserve vesicles, but rather a heterogeneous population differing in 
releasability (50). Other mechanisms also affect stimulus-secretion coupling, including 
changes in axonal excitability that result from activity-dependent changes in extracellular 
potassium concentration (51,52). In this study our purpose was not to construct a detailed 
model of all of the mechanisms that contribute to stimulus-secretion coupling, but rather to 
produce a minimalist model that by matching available data on stimulus-secretion coupling 
would enable us to predict secretion from spiking activity (31,52–54). 
Combining the spiking model with this secretion model allowed us to model the activity-
dependent output of oxytocin cells. To relate this to measurements of secretion in vivo, we 
needed to scale the output of the model by choosing an appropriate value for the scaling 
factor α. The in vitro measurements used to fit the model report variable absolute levels of 
oxytocin secretion; in these experiments glands are impaled on stimulating electrodes, and 
exactly where the glands are impaled will determine what proportion of the axons are 
stimulated, and there will be variable damage to axons. Stripping neural lobes from the 
adjacent intermediate lobe reduces the volume of tissue impaled and makes it more likely that 
the tissue is effectively stimulated, but entails greater tissue damage. In such experiments 
(55), 6 min of stimulation at 13 Hz released up to 9 ng oxytocin. Matching this with the 
secretion model suggests a value of α = 1.5 as a lower bound of plausible values. Wakerley 
and Lincoln (22) estimated stimulus-evoked release in lactating rats by stimulating the neural 
stalk and comparing the resultant increase in intramammary pressure with that evoked by i.v. 
injections of oxytocin: they estimated that about 1 mU was released by 4 s of stimulation at 
50 Hz, consistent with α = 2. However, the response to stimulation in vivo varies with the 
precise placement of the electrode and with the stimulus current used. There is one 
circumstance, which does not involve that uncertainty. In the anesthetised lactating rat, 
suckling evokes intermittent milk-ejection bursts in oxytocin neurons which typically contain 
between 50 and 100 spikes and which last for about 2 s. These bursts produce an abrupt rise 
in intramammary pressure that can be mimicked by i.v. injection of 0.5 - I mU oxytocin (1.1 - 
2.2 ng). The release of 2.2 ng oxytocin by 2 s of stimulation at 50 Hz in the model is closely 
approximated by a value of α = 3, which was chosen for subsequent tests of the model. 
To predict the consequences of oxytocin secretion for plasma concentrations, we also 
needed to model the clearance of oxytocin. Early studies in the rat studied clearance in two 
ways: by infusing oxytocin continuously and measuring the achieved concentration at 
equilibrium and the decline after stopping infusion (29), and by injecting large amounts as a 
bolus and measuring the decline (28). In the former case, experiments studied the 
mechanisms of clearance by clamping vessels to the kidneys and splanchnic area. These two 
sets of data could mostly be well matched by a two-compartment model, except that, in data 
from rats with venous clamps, oxytocin concentrations remained elevated above predicted 
levels in a way that Fabian et al. (29) proposed arose from a time and surgery-dependent 
increase in the apparent distribution volume. This, we did not attempt to mimic in the model. 
Having selected a value for α, and with a validated model for plasma clearance of 
oxytocin, we could use the model to predict the changes in plasma concentration that result 
from the response of oxytocin neurons to CCK. For this, we had four sets of data in which 
oxytocin was measured in different conditions (conscious and anaesthetised rats, male and 
female rats) at two different doses of CCK and using two different radioimmunoassays. 
Matching the initial basal level of secretion in these data implied differences in the basal 
firing rates of oxytocin neurons in the four conditions. The mean basal firing rates inferred 
from the model were 2.4 spikes/s for conscious female rats (Fig 6c1), 0.8 spikes/s for 
conscious male rats (Fig 6c2), and 1.7 spikes/s and 0.9 spikes/s for urethane-anaesthetised 
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female rats (Figs 6c3-4). These are lower than the basal firing rates recorded from the 
supraoptic nucleus of urethane-anaesthetised virgin female rats which are generally about 2.5 
spikes/s (37,56), but this difference is as expected, given that the electrophysiological 
recordings are from rats in which the hypothalamus has been exposed by transpharyngeal 
surgery. The trauma and blood loss entailed in this surgery increases the basal activity of both 
oxytocin and vasopressin neurons. Across these four sets of data there is good agreement 
between model predictions of the response to CCK and experimentally measured levels. 
We went on to use the model to investigate the role of the AHP. This activity-dependent 
potential, which is pronounced after high frequency spiking, is important in shaping the 
profile of milk-ejection bursts (57). However, the AHP is also active at low basal firing rates, 
and it both restrains basal activity and reduces the variability of firing rate (21). Secretion is 
coupled non-linearly to firing rate, and as a result, variability of firing rate produces an 
amplified variability of secretion. 
The extent of this variability is illustrated in Fig. 8, which shows that for an oxytocin 
neuron firing at 7 spikes/s, the secretion in 6-s bins is very variable, but is always distinct 
from the secretion resulting from a firing rate of 4 spikes/s. However, for a neuron without an 
AHP there is considerable overlap: the mean spike rate cannot be reliably estimated from the 
secretion measured in a given 6-s bin. This variability is of little consequence to plasma 
levels in the rat: oxytocin in plasma has a half-life of about a minute, and levels reflect the 
activity of about 9000 neurons. However, for smaller animals, such variability may be more 
problematic. In zebrafish for example, the ortholog of oxytocin, isotocin, is expressed in only 
a few tens of neurons (58). 
In mammals, small subsets of magnocellular neurons project to diverse sites in the brain, 
and at these sites, stability of oxytocin secretion rates might also be important. We have 
shown (Fig 9) that even changes in spike activity that have large functional consequences (1 
spike/s) cannot be consistently detected as changes in secretion from a single neuron unless 
secretion is averaged over many seconds. Without an AHP, only the average secretion over 
30 s will consistently reveal a rise in mean firing rate. Thus, the output of a single oxytocin 
neuron is a very noisy reflection of the signal that determines the mean level of its afferent 
inputs, but the presence of an AHP markedly enhances its signal detection ability. This may 
be important for a small population of neurons, including for the small subsets of oxytocin 
neurons that project to various forebrain sites, but is much less important for the large 
population that projects to the pituitary. 
An important consideration in inferring physiological significance to the behavior of a 
single neuron is how population heterogeneity may temper those inferences. Oxytocin 
neurons are certainly heterogeneous – in their basal firing rates, in their responsiveness to 
physiological stimuli, and in their intrinsic membrane properties including those that 
determine the HAP and the AHP. Here we  
simulated some of this heterogeneity by running our single neuron model with varied 
synaptic input rates, and by introducing variability into the simulated CCK challenge. The 
activity dependence of the AHP means that it has a stronger inhibitory effect on more active 
neurons, pulling them closer to the mean firing rate. Thus, as well as reducing signal 
variability within single neurons, the AHP reduces the variability of firing rate of a 
heterogeneous population (Fig. 10), with an even larger effect on the variability of secretion 
rate because of the non-linear coupling of firing rate to secretion. 
A full appreciation of the effects of heterogeneity is beyond the scope of the present 
paper. It remains to be determined how variability in intrinsic properties interacts with 
variability in input rates, and how variability in the population signal affects secretion might 
depend on assumptions about the independence of input signals. Each oxytocin neuron 
receives many synaptic inputs, and it is likely that these are from overlapping subsets of a 
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larger pre-synaptic population, resulting in many neurons receiving the same input noise. 
There is extensive data already in the literature on both the electrophysiological responses of 
oxytocin neurons to different stimuli and on associated plasma oxytocin responses, giving a 
potentially rich source of material to test and refine the present model. 
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Figure 1. The combined spiking, secretion, and diffusion model. The integrate-and-fire 
based spiking model responds to randomly arriving PSPs. The i.v. injection of CCK is 
simulated as an exponentially decaying increment in the mean arrival rate of EPSPs. The 
resulting spikes become the input of the secretion model. In that model, spike-induced Ca2+ 
entry at secretory terminals is positively modulated by activity-dependent spike broadening 
(b), and negatively modulated by fast (e) and slow (c) Ca2+ variables that inhibit spike-
induced opening of Ca2+ channels (24). The secretion rate (s) is the product of the releasable 
pool (p) and e. When depleted, pool p is refilled from a reserve pool (r) at a rate dependent on 
the pool content. Oxytocin in plasma (x) is cleared with an exponential decay, and diffuses 
between the plasma and extravascular fluid (xEVF) according to the concentration gradient. 
Figure 2. Responses of oxytocin neurons to CCK, and simulation in model cells. a) The 
average response (in 1-s bins) of 23 oxytocin neurons to i.v. injection of 20 µg/kg CCK. The 
response decays exponentially with a best-fit half-life of 230 s (dotted line). b) Response of a 
model oxytocin cell to a simulated challenge with CCK, simulated as an increase in PSP rate 
that decays exponentially with a half-life of 230 s, matching the measured half-life of CCK in 
plasma. The simulation was run 23 times with different random seeds, and the figure shows 
the average (see Tables 1&2 for model parameters). c1) A typical response to CCK from a 
single oxytocin cell (white dots). With a model cell (black dots) that has a HAP and an AHP 
it is possible to match this response closely. Parameter values for the model are in Table 1. 
c2) In this simulation, CCK increases the EPSP rate: the increase decays exponentially with a 
half-life of 230 ms. c3) The ISI distribution, constructed from the complete activity shown in 
c1, shows how often two consecutive spikes have a particular distance between them; the 
distribution from the model cell (black dots) closely matches that of the recorded cell (white 
dots). c4) The index of dispersion measures longer timescale spike patterning, showing how 
spike rate variability changes using different bin widths, again from the entire activity shown 
in c1). The model (black bars) closely matches the values measured in the recorded oxytocin 
neuron (white bars). 
Figure 3. Oxytocin secretion model dynamics. Oxytocin secretion follows a non-linear 
function of the spiking activity. We adapted a previous model of vasopressin secretion (white 
squares) (24), modifying six parameter values to obtain our oxytocin model (white triangles). 
With those changes, we matched the oxytocin secretion from experiments (white circles). a1) 
AD
VA
N
CE
 A
RT
IC
LE
:
En
d
o
cr
in
o
lo
g
y
Downloaded from https://academic.oup.com/endo/advance-article-abstract/doi/10.1210/en.2017-03068/4801229
by Edinburgh University user
on 05 February 2018
AD
VA
NC
E 
AR
TI
CL
E
Endocrinology; Copyright 2018  DOI: 10.1210/en.2017-03068 
 
 
18
In Bicknell’s experiments (26), when posterior pituitaries were electrically stimulated with 
156 pulses at 6.5, 13, 26 and 52 Hz, vasopressin secretion (white squares) was maximal at 13 
Hz. By contrast, oxytocin secretion (white circles) continued to increase up to 52 Hz. a2) 
Matching the data from Bicknell (26) with the oxytocin model. a3) Using the same 
parameters, we also obtained a good match to data from Bondy et al. (27). In those 
experiments, glands were stimulated with 600 pulses at 1, 4, 8, 12, 20 and 30 Hz, and evoked 
secretion (S2) was expressed as a ratio of S1, a reference secretion produced by a preceding 
stimulus at 12 Hz. b1) In Bicknell et al. (25), glands were stimulated at 13 Hz for 18-72 s: 
vasopressin secretion peaked during the first 18 s and showed subsequent fatigue (white 
squares), whereas oxytocin showed a consistent response (white circles). b2) We matched 
that response with the model using the same parameters as in a2) and a3). c) The six 
parameters changed from the model of vasopressin secretion (24). 
Figure 4. Transition from a vasopressin secretion model to an oxytocin secretion model. 
In both models, secretion is proportional to the submembrane Ca2+ concentration e. We show 
here how e changes during 24-s of stimulation at constant rates of 6.5, 13, 26 and 52 spikes/s. 
a) In the vasopressin model, for stimulations at 13, 26 and 52 spikes/s, e reaches a peak 
during the first 2 s of stimulation, followed by fatigue. Neither the fatigue, nor the early peak 
is present at 6.5 spikes/s. To obtain the frequency facilitation seen in Fig. 3, we need to 
eliminate the fatigue at 13 spikes/s and increase the response at higher frequencies. b1) 
Decreasing kb produces less saturation at high frequencies, increasing the difference between 
responses. b2) Increasing eθ increases the peak response, especially at higher spike rates, but 
does not reduce the fatigue. b3) Increasing cθ eliminates the fatigue but does not separate the 
responses to different stimulation frequencies. c) Combining these three changes reproduces 
the frequency-facilitation of secretion while eliminating fatigue at 13 spikes/s. 
Figure 5. Oxytocin spiking and secretion response to CCK. a1) Model oxytocin neurons 
respond to CCK by increasing their spike activity independently of the basal firing rate. The 
graph shows the increments in spike activity of a model cell responding to simulated 
challenges with different amounts of CCK (5, 10 and 20 µg/kg), from different basal firing 
rates (1, 3, 5, and 7 spikes/s). The same model neuron was tested 20 times, receiving random 
PSPs with the same average rate of 165, 348, 583, and 895 PSPs/s. a2) In the same 
simulations as in a1, the secretion response depends on the basal firing rate. b1) Large 
differences in basal firing rate (1 spike/s in black, 7 spikes/s in grey) do not drastically 
change the firing rate response to CCK. b2) The same simulations as in b1 but in a model cell 
without an AHP. The presence of an AHP greatly reduces the response to CCK. b3,4) 
Secretion corresponding to the simulations in b1,2. The evoked secretion is strongly affected 
by the basal firing rate due to the non-linearity of the secretion response. In b4, the secretory 
response to CCK in a model cell with a basal firing rate of 7 spikes/s and no AHP shows a 
marked initial peak. c1) When a model cell firing at 1 spike/s is challenged with a large CCK 
injection (40 µg/kg), the firing rate response closely follows the change in the model variable 
e. c2) The secretory response to the challenge illustrated in c1. c3) In response to a still larger 
challenge (100 µg/kg CCK), the firing rate response has a similar shape as in c1). However, e 
follows an acute initial increment that is not maintained, due to the negative feedback 
provoked by [Ca2+]. c4) Due to those changes in e, amplified because secretion is 
proportional to e2, oxytocin secretion follows the biphasic pattern observed in b4. 
Figure 6. Two-compartment diffusion model and oxytocin plasma response to CCK. We 
calibrated our two-compartment diffusion model with data from two i.v. oxytocin protocols: 
after a long infusion and after a bolus injection. We then simulated the plasma oxytocin 
AD
VA
N
CE
 A
RT
IC
LE
:
En
d
o
cr
in
o
lo
g
y
Downloaded from https://academic.oup.com/endo/advance-article-abstract/doi/10.1210/en.2017-03068/4801229
by Edinburgh University user
on 05 February 2018
AD
VA
NC
E 
AR
TI
CL
E
Endocrinology; Copyright 2018  DOI: 10.1210/en.2017-03068 
 
 
19
response to CCK to compare with four experimental datasets. a) Oxytocin clearance after 30-
min infusion of 3 ng/100g body weight/min oxytocin. Black dots, white triangles and light 
grey diamonds show the plasma oxytocin measured (29) in normal rats (black circles), rats 
with the kidneys or the splanchnic area clamped (grey triangles) and rats with both set of 
organs clamped (grey squares). Thick, normal, and thin black lines are the model results 
following simulations of the same protocol. The parameter values are given in Table 3. b) 
Mean (SE) plasma oxytocin after bolus (2-s) injection of 440 µg/100g of oxytocin ((28), 
white dots), matched (black line) by a model with the same parameter values as used in a). c) 
Adding the diffusion model to the spiking and secretion models (solid lines), we can match 
the CCK experimental response in plasma (open circles with SE shown) from four data sets 
by changing the basal PSP rate to match the first experimental point, and emulating the 
amount of CCK injected. c1) Data from 23 conscious female rats injected with 20 µg/kg 
CCK (38). c2) Data from 5-10 conscious male rats given 10 µg/kg CCK (19). c3) and c4) 
Anesthetized female rats injected with 20 µg/kg CCK from (39). Modeled data are shifted by 
60 s in c1 to c4, assuming that the CCK injections were given slowly. The other model 
parameters are as obtained to match the spiking response to CCK (Table 1). 
Figure 7. The effect of the AHP. The AHP affects the baseline behavior and the response to 
CCK (20 µg/kg i.v.) in the spike rate (a), secretion (b) and plasma concentration (c). SD: 
standard deviation during the 1200-s period before CCK injection. a) The model was set to 
produce a basal mean firing rate of 1 spike/s, which increased to 4.9 spikes/s after CCK 
(black). Removing the AHP (grey), but keeping the same initial PSP rate, produces a slightly 
higher basal firing rate and a much greater response to CCK. The basal firing rate, measured 
between 800 and 2000 s, is less variable with an AHP than without it as apparent from the SD 
(bars). b) Secretion is a non-linear function of the firing rate. When there is a fast change in 
firing rate, the non-linearity provokes a very much larger secretory response in a model 
without an AHP. The basal secretion rate is much less variable with an AHP than without it. 
c) Without an AHP, the oxytocin plasma concentration increases hugely in response to CCK 
injection. Before CCK, the basal oxytocin concentration in plasma is much less variable with 
an AHP than without it. 
Figure 8. The role of the AHP in signal response. (a-b) Average firing rate of 20 runs of 
the same model cell. We compare average spiking and secretion responses to CCK when 
there is an AHP in the model (a and c) and when there is not (b and d). Means are in black 
and SD in grey. a) Modeling a basal firing rate of 1.5 spikes/s with a PSP rate of 210/s and an 
AHP. In response to a simulated injection of 10 µg/kg, the model cell responds with an 
increment of ~ 2 spikes/s. b) To obtain a similar average response without an AHP, we 
reduced the PSP rate to 165/s and the CCK injection to 5 µ g/kg. Although the mean 
responses are similar, the SD (grey) is much larger without an AHP. c) and d). Secretion rates 
accompanying the firing rate simulations in a) and b). Secretion shows an even bigger 
difference in variability without an AHP due to the non-linearity between secretion and firing 
rate. e) Another way to see the role of the AHP is to look at oxytocin secretion in 4-s intervals 
in response to PSPs at a constant mean rate. In models with and without an AHP, PSP rates 
were chosen to produce mean firing rates of 1, 4 and 7 spikes/s (large diamonds). Because of 
the randomness of PSP arrival times, the firing rate varies from interval to interval around 
these means, and this variability is greater without an AHP. This variability is amplified by 
the non-linearity of stimulus-secretion coupling. The dot clouds represent the firing rates in 6-
s intervals and the concurrent secretion during 1200s when the modeled neuron produces 
average firing rates of 1 (dark grey crosses), 4 (grey circles) and 7 spikes/s (black pluses). In 
a model with an AHP, the firing rates and secretion measured in every interval both 
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consistently distinguish the three levels of PSP rate. In a model without an AHP, there is 
extensive overlap. 
Figure 9. The role of the AHP in the detection of a transient signal. a) We ran the model 
as a single neuron with a mean basal firing rate (FR) of 1, 3 and 7 spikes/s. By modifying the 
EPSP rate, we raised the firing rate by an average of 1 spike/s for a 10-s challenge episode 
every 20 s for 100 min. The graphs plot the model outputs (firing rate, secretion per second 
and secretion per 10-s) for a model neuron firing at 3 spikes/s for the first 100 s of the 
simulation. b) as in a) but for a model with no AHP. Note that in a), episodes of greater EPSP 
rate are consistently associated with greater secretion (as measured in 10-s bins), but this is 
not true of a model with no AHP. b)-e) Similar experiments to those in a) and b) were 
performed to assess challenge episodes of different duration (1, 3, 5, 10, 15, 30 and 50 s). c) 
Shows the percentage of errors for a neuron firing at a basal firing rate of 1, 3 and 7 spikes/s 
when there is an AHP. d) Same but without an AHP. In all cases, there is a much smaller 
error rate when there is an AHP. 
Figure 10. Heterogeneity in oxytocin spiking activity and response to CCK. From left to 
right, each set of panels shows the average firing rate of the 23 neurons (in 1-s bins), the SD 
of the firing rate, the predicted in vivo secretion (in 1-s bins), and the SD of the predicted 
secretion. a). shows data from the 23 reference neurones. b1) Averages of 23 runs of the 
model with random PSP arrival times at a fixed PSP rate. The SD of the basal firing rate is 
much smaller than in a, and does not increase after CCK. The basal secretion is lower than in 
a but the increment after CCK (~20 pg/s) is similar. The SD in the model is also much lower 
than in a. b2) To simulate heterogeneity in oxytocin neurons, we varied the basal PSP rate 
using a lognormal distribution. The heterogeneity elevates the SD to the level in a, but the SD 
still does not increase after CCK. The secretion is close to that in a. b3) Adding heterogeneity 
to the response to CCK gives a very close match to all panels in a. c1) In 23 homogeneous 
model cells without an AHP, a match to the mean firing rates of the reference neurons is 
obtained by reducing the basal PSP rate and kCCK. The SD of the firing rate is lower than in a 
but higher than in b1. The basal secretion and the SD of secretion are lower than in a. c2) 
Adding heterogeneity to the model without an AHP produced a higher basal firing rate and 
smaller response to CCK, but greatly increased the SD of the firing rate and the secretion rate 
to levels much higher than in a. Thus a close match to both the mean and the variability of the 
reference data (a) was obtained by modeling a population of neurons matching the 
heterogeneity of those data using a model with an AHP, but not by using a model without an 
AHP. The parameter changes used for the simulations shown are given in Table 5. 
Table 1. Top) Parameters of the integrate-and-fire spiking model, with parameter values 
chosen from (21) and CCK parameters, as used for the simulations in Fig. 2b. Bottom). 
Parameter changed from Top) to match a single oxytocin neuron recording as seen in Fig 2c. 
In subsequent simulations, Ire and Iri were kept equal to each other but were varied to 
produce different basal firing rates as appropriate; the other parameters were unchanged from 
the upper table. 
Name Description Value Units 
Ire excitatory input rate 292 Hz 
Iri inhibitory input rate 292 Hz 
epsph  EPSP amplitude 2 mV 
ipsph IPSP amplitude -2 mV 
λsyn PSP half-life 3.5 ms 
kHAP HAP amplitude per spike 30 mV 
λHAP HAP half-life 7.5 ms 
kAHP AHP amplitude per spike 1 mV 
λAHP AHP half-life 350 ms 
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Vrest resting potential -56 mV 
Vthresh spike threshold potential -50 mV 
λCCK CCK half-life in plasma 230 s 
CCKdur CCK injection duration 20 s 
kCCK CCK i.v. injection 20 µg/kg 
Ire excitatory input rate 210 Hz 
Table 2. Secretion model parameter values, modified from the parameters used for a model 
of vasopressin secretion (24) as described in the Results. 
Name Description Value Units 
kb broadening per spike 0.021 - 
λb broadening half-life 2000 ms 
bbase  basal spike broadening 0.5 - 
kc max cytosolic Ca2+ per spike 0.0003 - 
λc cytosolic Ca2+ half-life 20000 ms 
ke max submembrane Ca2+ per spike 1.5 - 
λe submembrane  Ca2+ half-life 100 ms 
cθ threshold, terminal inhibition by c 0.14  
cn gradient, terminal inhibition by c 5  
eθ threshold, terminal inhibition by e 12  
en gradient, terminal inhibition by e 5  
β pool refill rate scaling factor 120  
rmax reserve store maximum 1000 ng 
pmax reserve pool maximum 5 ng 
α Secretion scaling factor 3  
φ 
cooperativeness of the Ca2+ 
activation of exocytosis 2  
Table 3. Diffusion model parameter values. The upper section gives values measured 
experimentally. The middle section gives parameter values used in the diffusion model. The 
bottom line shows model measurements from simulations of the experiments. 
Parameter Description Normal rat 
Kidneys or 
splanchnic 
clamped 
Both 
clamped Normal rat 
 Experiments Fabian et al. (29) Ginsburg & Smith (28) 
 Plasma oxytocin half-life (s) 126 380 480 99 
 Total fluid volume (ml) 18.25 37.5 35.75 No data 
 Duration of oxytocin infusion (s) 1800 - - 2 
      
λclr clearance half-life (s) 68 135 188 68 
λdiff diffusion half-life (s) 61 - - - 
Cplasma plasma volume (ml) 8.5 - - - 
CEVF Extravascular fluid volume (ml) 9.75 - - - 
 Plasma oxytocin half-life (s) 126 379 479 91 
Table 4. Peak concentration for the two-compartment diffusion model. 
Fabian et al. (29) 30 min 
infusion 
Oxytocin Infusion  
ng/100g/ml 
Peak concentrations (ng/ml) 
Fabian et al. (29) Model 
0.550 0.220 0.270 
3 - 1.447 
13.2 6.160 6.347 
Ginsburg & Smith (28)  
Injection 
Oxytocin injection 
ng/100g 
Peak concentration after 60 s (ng/ml) 
Ginsburg & Smith (28) Model 
440 45.32 (+/- 6.27) 43.48 
Table 5. Spiking parameter values to simulate heterogeneity in an oxytocin neuron 
population as shown in Fig 10 and 11.  
 With an AHP Without an AHP 
Neuron Model Random basal firing rate 
Random basal FR 
and  CCK response Model 
Random basal FR 
and  CCK 
response 
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Ire & Iri kCCK Ire & Iri kCCK Ire & Iri kCCK Ire & Iri kCCK Ire & Iri kCCK 
1 
292 20 
112 
20 
112 13.9 
203,5 7 
71 16.1 
2 63 63 7.5 322 3.7 
3 68 68 5.6 101 2.5 
4 92 92 55.3 490 1.7 
5 180 180 18.0 71 5.2 
6 74 74 12.0 292 6.1 
7 278 278 8.2 208 5.1 
8 488 488 5.5 85 8.0 
9 203 203 8.0 43 6.5 
10 69 69 8.7 335 5.4 
11 237 237 10.5 587 12.3 
12 279 279 16.8 104 3.8 
13 411 411 41.0 622 1.1 
14 156 156 14.0 114 13.2 
15 494 494 23.4 83 25.5 
16 383 383 41.7 63 3.9 
17 218 218 35.1 240 4.0 
18 699 699 2.3 36 3.5 
19 204 204 27.3 410 12.7 
20 1026 1026 20.6 104 3.2 
21 67 67 15.8 127 5.0 
22 335 335 38.9 129 10.8 
23 574 574 37.2 45 2.0 
Average 291.7 291.7 20.3 203.7 7.0 
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